We also examined a Ph+ ALL cell line expressing the p190 form of BCR/ABL, TMD-5, and found that PECAM-1 was also tyrosine phosphorylated in these cells and was dephosphorylated after treatment with imatinib (Fig. 1D and E). This evidence concerns the gene BCR and acute lymphoblastic leukemia.